Is antimicrobial resistance a bigger problem in tertiary care hospitals than in small community hospitals in the United States?

Sumanth Gandra; Anna Trett; Eili Y. Klein; Ramanan Laxminarayan

doi:10.1093/cid/cix413

Is antimicrobial resistance a bigger problem in tertiary care hospitals than in small community hospitals in the United States?

Sumanth Gandra, Anna Trett, Eili Y. Klein, Ramanan Laxminarayan

Research output: Contribution to journal › Article › peer-review

Abstract

Large tertiary care hospitals (TCHs) are thought to have higher antimicrobial resistance (AMR) rates when compared to small community hospitals (SCHs) as they provide care to patients with higher disease severity. However, we found no systematic differences in AMR rates between TCHs and SCHs in the United States.

Original language	English (US)
Pages (from-to)	860-863
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	65
Issue number	5
DOIs	https://doi.org/10.1093/cid/cix413
State	Published - Sep 1 2017
Externally published	Yes

Keywords

Antimicrobial resistance
Small community hospitals
Tertiary care hospitals

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/cix413

Cite this

@article{a781a8d9a57d4a8f890de99fa02af099,

title = "Is antimicrobial resistance a bigger problem in tertiary care hospitals than in small community hospitals in the United States?",

abstract = "Large tertiary care hospitals (TCHs) are thought to have higher antimicrobial resistance (AMR) rates when compared to small community hospitals (SCHs) as they provide care to patients with higher disease severity. However, we found no systematic differences in AMR rates between TCHs and SCHs in the United States.",

keywords = "Antimicrobial resistance, Small community hospitals, Tertiary care hospitals",

author = "Sumanth Gandra and Anna Trett and Klein, {Eili Y.} and Ramanan Laxminarayan",

note = "Funding Information: Financial support. The research was funded by the Bill & Melinda Gates Foundation through a grant to CDDEP (OPP1112355) in support of the ResistanceMap project (SG, EK, RL). AT is supported by the Global Antibiotic Resistance Partnership, which is funded by the Bill & Melinda Gates Foundation. Publisher Copyright: {\textcopyright} Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2017",

month = sep,

day = "1",

doi = "10.1093/cid/cix413",

language = "English (US)",

volume = "65",

pages = "860--863",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",